Company intelligence / Profile preview
betapharm Arzneimittel
Augsburg, Bavaria, Germanybetapharm.de ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
betapharm Arzneimittel is a leading German pharmaceutical company specializing in the development and commercialization of high-quality generic medicines. It operates as a major player in the German generics market and was acquired by Dr. Reddy’s Laboratories in 2006 for €480 million ($570 million). The company continues to provide affordable healthcare solutions with a focus on quality and accessibility.
- Therapeutic areas
- Other
- Modalities
- Small moleculeGeneric drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Leverages parent company Dr. Reddy’s global manufacturing and product development infrastructure
Beyond the preview
Go deeper on betapharm Arzneimittel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on betapharm Arzneimittel.